Suppr超能文献

ST 段抬高型心肌梗死:法国 COVID-19 大流行期间的管理和预后相关性。

ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France.

机构信息

Université de Paris, Paris Cardiovascular Research Center (PARCC), INSERM, UMR-S970, 75015 Paris, France.

Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, 13015 Marseille, France.

出版信息

Arch Cardiovasc Dis. 2021 May;114(5):340-351. doi: 10.1016/j.acvd.2021.01.005. Epub 2021 Apr 14.

Abstract

BACKGROUND

Systems of care have been challenged to control progression of the COVID-19 pandemic. Whether this has been associated with delayed reperfusion and worse outcomes in French patients with ST-segment elevation myocardial infarction (STEMI) is unknown.

AIM

To compare the rate of STEMI admissions, treatment delays, and outcomes between the first peak of the COVID-19 pandemic in France and the equivalent period in 2019.

METHODS

In this nationwide French survey, data from consecutive STEMI patients from 65 centres referred for urgent revascularization between 1 March and 31 May 2020, and between 1 March and 31 May 2019, were analysed. The primary outcome was a composite of in-hospital death or non-fatal mechanical complications of acute myocardial infarction.

RESULTS

A total of 6306 patients were included. During the pandemic peak, a 13.9±6.6% (P=0.003) decrease in STEMI admissions per week was observed. Delays between symptom onset and percutaneous coronary intervention were longer in 2020 versus 2019 (270 [interquartile range 150-705] vs 245 [140-646]min; P=0.013), driven by the increase in time from symptom onset to first medical contact (121 [60-360] vs 150 [62-420]min; P=0.002). During 2020, a greater number of mechanical complications was observed (0.9% vs 1.7%; P=0.029) leading to a significant difference in the primary outcome (112 patients [5.6%] in 2019 vs 129 [7.6%] in 2020; P=0.018). No significant difference was observed in rates of orotracheal intubation, in-hospital cardiac arrest, ventricular arrhythmias and cardiogenic shock.

CONCLUSIONS

During the first peak of the COVID-19 pandemic in France, there was a decrease in STEMI admissions, associated with longer ischaemic time, exclusively driven by an increase in patient-related delays and an increase in mechanical complications. These findings suggest the need to encourage the population to seek medical help in case of symptoms.

摘要

背景

医疗系统一直在努力控制 COVID-19 大流行的发展。在法国,这是否与 ST 段抬高型心肌梗死(STEMI)患者的再灌注延迟和预后恶化有关尚不清楚。

目的

比较法国 COVID-19 大流行第一波和 2019 年同期的 STEMI 入院率、治疗延迟和结局。

方法

本项全国性法国调查分析了 2020 年 3 月 1 日至 5 月 31 日和 2019 年同期 65 个中心因紧急血运重建而转诊的连续 STEMI 患者的数据。主要结局是院内死亡或急性心肌梗死非致命机械并发症的复合结局。

结果

共纳入 6306 例患者。在大流行高峰期,每周 STEMI 入院人数减少了 13.9±6.6%(P=0.003)。与 2019 年相比,2020 年症状发作至经皮冠状动脉介入治疗的时间更长(270[四分位距 150-705]比 245[140-646]min;P=0.013),这主要是由于症状发作至首次医疗接触的时间增加(121[60-360]比 150[62-420]min;P=0.002)。2020 年,机械并发症的数量更多(0.9%比 1.7%;P=0.029),导致主要结局的差异具有统计学意义(2019 年 112 例[5.6%],2020 年 129 例[7.6%];P=0.018)。气管插管、院内心脏骤停、室性心律失常和心源性休克的发生率无显著差异。

结论

在法国 COVID-19 大流行的第一波期间,STEMI 入院率下降,与缺血时间延长有关,这主要是由于患者相关延迟增加和机械并发症增加所致。这些发现表明需要鼓励民众在出现症状时寻求医疗帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60c/9056233/20a57eb066ce/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验